A clinical trial update was recorded on August 28, 2026, for a study titled "Oral Thiamine (Vitamin B1) for Depression in Children and Adolescents." The trial, registered as NCT07793071, is listed as Phase 2 and has a status of not yet recruiting. According to the registry entry, the study has not yet begun enrolling participants as of this update. No results, outcomes, or enrollment figures have been reported at this stage. The trial record does not include additional details on design, comparator, or timeline beyond its current status. This update reflects only the registration status recorded on ClinicalTrials.gov and does not indicate any findings about safety or effectiveness. Readers interested in this trial can consult the official registry listing for further protocol details as they become available. For general background on leptin, readers can refer to the compound overview.
Trial Update: Oral Thiamine for Pediatric Depression Not Yet Recruiting
Source: https://clinicaltrials.gov/study/NCT07793071